Moreover, in both female (Fig. 1H, P < 0.01) and male (Fig. 1I, P = 0.067) NSCLC patient subgroups, PRR15 overexpression correlates with poor overall survival. The gene discussed is PRR15; the disease is non-small cell lung carcinoma.